NO179948C - Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse - Google Patents

Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse

Info

Publication number
NO179948C
NO179948C NO932731A NO932731A NO179948C NO 179948 C NO179948 C NO 179948C NO 932731 A NO932731 A NO 932731A NO 932731 A NO932731 A NO 932731A NO 179948 C NO179948 C NO 179948C
Authority
NO
Norway
Prior art keywords
quinolylmethoxyphenyl
acid amides
isobutyl
new
methanesulfonyl
Prior art date
Application number
NO932731A
Other languages
English (en)
Norwegian (no)
Other versions
NO932731D0 (no
NO179948B (no
NO932731L (no
Inventor
Siegfried Raddatz
Klaus-Helmut Mohrs
Michael Matzke
Romanis Fruchtmann
Reiner Mueller-Peddinghaus
Armin Hatzelmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO932731D0 publication Critical patent/NO932731D0/no
Publication of NO932731L publication Critical patent/NO932731L/no
Publication of NO179948B publication Critical patent/NO179948B/no
Publication of NO179948C publication Critical patent/NO179948C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO932731A 1992-08-12 1993-07-29 Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse NO179948C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226649A DE4226649A1 (de) 1992-08-12 1992-08-12 Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole

Publications (4)

Publication Number Publication Date
NO932731D0 NO932731D0 (no) 1993-07-29
NO932731L NO932731L (no) 1994-02-14
NO179948B NO179948B (no) 1996-10-07
NO179948C true NO179948C (no) 1997-01-15

Family

ID=6465373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932731A NO179948C (no) 1992-08-12 1993-07-29 Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse

Country Status (19)

Country Link
EP (1) EP0582916A1 (ko)
JP (1) JPH06157462A (ko)
KR (1) KR940003937A (ko)
CN (1) CN1039998C (ko)
AU (1) AU669913B2 (ko)
CA (1) CA2103600A1 (ko)
CZ (1) CZ282341B6 (ko)
DE (1) DE4226649A1 (ko)
FI (1) FI933529A (ko)
HU (1) HUT70171A (ko)
IL (1) IL106623A0 (ko)
MX (1) MX9304608A (ko)
MY (1) MY108716A (ko)
NO (1) NO179948C (ko)
NZ (1) NZ248350A (ko)
PL (1) PL174102B1 (ko)
RU (1) RU2103261C1 (ko)
SK (1) SK86693A3 (ko)
ZA (1) ZA935828B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US5931170A (en) * 1998-10-08 1999-08-03 Addway Engineering Limited Dental flosser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren

Also Published As

Publication number Publication date
AU669913B2 (en) 1996-06-27
DE4226649A1 (de) 1994-02-17
IL106623A0 (en) 1993-12-08
FI933529A0 (fi) 1993-08-10
MX9304608A (es) 1994-02-28
PL174102B1 (pl) 1998-06-30
RU2103261C1 (ru) 1998-01-27
CZ163693A3 (en) 1994-03-16
CA2103600A1 (en) 1994-02-13
NZ248350A (en) 1994-12-22
MY108716A (en) 1996-11-30
SK86693A3 (en) 1994-09-07
FI933529A (fi) 1994-02-13
NO932731D0 (no) 1993-07-29
HU9302320D0 (en) 1993-10-28
CN1087084A (zh) 1994-05-25
NO179948B (no) 1996-10-07
JPH06157462A (ja) 1994-06-03
AU4425593A (en) 1994-02-17
ZA935828B (en) 1994-03-10
EP0582916A1 (de) 1994-02-16
CN1039998C (zh) 1998-09-30
CZ282341B6 (cs) 1997-07-16
HUT70171A (en) 1995-09-28
KR940003937A (ko) 1994-03-14
NO932731L (no) 1994-02-14
PL300025A1 (en) 1994-03-21

Similar Documents

Publication Publication Date Title
NO955034D0 (no) Nye substituerte 1H-imidazoler og farmasöytiske preparater inneholdende disse
NO180232C (no) Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler
NO924978L (no) Chinolon- og naftyridon-karboksylsyrederivater
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
DE69327326D1 (de) Vervielfältigungs- und detektionsprozess
NO180145C (no) Tannbörste og tildannelse av samme
DE69402892T3 (de) Gefrierverfahren und -vorrichtung
NO954975D0 (no) Aromatisk substituerte w-amino-alkansyreamider og alkansyrediamider
DE69420687T2 (de) Anzeigevorrichtung und -verfahren
NO930760D0 (no) Substituerte fenyleddiksyreamider
DE69301673D1 (de) Anzeigevorrichtung und Herstellungsverfahren
DE69322103D1 (de) Auswerteverfahren und -geraet der seismik
DE69214395D1 (de) Fluortolane und flüssigkristalline media
NO930722L (no) Imidazolylsubstituerte fenyleddiksyreamider
DE69418583T2 (de) Überwachung von Zweiwegleitungen
NO934426D0 (no) Nye amidoalkyl- og imidoalkylpipera-ziner
DE69320882D1 (de) Entwicklungsgerät und -verfahren
NO960414L (no) Anvendelse av fenylcykloheksylkarboksylsyreamider
IS3611A7 (is) Aromatísk karboxýl amíð og aðferð til framleiðsluþeirra
NO179948C (no) Nye isobutylsubstituerte metansulfonyl-kinolylmetoksyfenyl-cykloalkyleddiksyreamider og anvendelse av disse
DE69309572D1 (de) Auftragsverfahren und -vorrichtung
IS4140A (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO940840D0 (no) Drivstoff i flytende form - produksjonsmetode og bruk av denne
NO924466L (no) Chinolylmetoksyfenyleddiksyre-acylamider og -urinstoffer
FR2632107B1 (fr) Element d'affichage et procede et appareil d'affichage utilisant cet element